Supplementary Appendix from Prevalence of Cervical Human Papillomavirus (HPV) Infection in Vanuatu
Bernadette Aruhuri, Silvia Franceschi(Centro di Riferimento Oncologico), Rohit Sinha, Ian H. Frazer(The University of Queensland), Peter J.F. Snijders(Amsterdam UMC Location VUmc), Chris J.L.M. Meijer(Dutch Cancer Society), James C. Pang(Australian Regenerative Medicine Institute), Vanessa Tenet, Len Tarivonda, Gary M. Clifford(Centre international de recherche sur le cancer), Margaret McAdam
Cited by 0
Related Papers
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
|The Lancet Global Health|2019|2.4k
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review
|Cancer Epidemiology Biomarkers & Prevention|2005|2.2k
Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update
|International Journal of Cancer|2007|1.7k
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis
|The Lancet Infectious Diseases|2007|1.7k
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
|British Journal of Cancer|2003|1.6k